These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28802881)

  • 1. Recent Topics of Research in the Characterization and Quality Control of Biopharmaceuticals in Japan.
    Ishii-Watabe A; Shibata H; Harazono A; Hyuga M; Kiyoshi M; Saitoh S; Iwura T; Torisu T; Goda Y; Uchiyama S
    J Pharm Sci; 2017 Dec; 106(12):3431-3437. PubMed ID: 28802881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Achievements and Current Interests in Research on the Characterization and Quality Control of Biopharmaceuticals in Japan.
    Ishii-Watabe A; Shibata H; Suetomo H; Ikeda Y; Telikepalli S; Kiyoshi M; Hayashi Y; Muto T; Tanaka Y; Ueda S; Iwura T; Saitoh S; Aoyama M; Harazono A; Hyuga M; Goda Y; Torisu T; Uchiyama S
    J Pharm Sci; 2020 May; 109(5):1652-1661. PubMed ID: 31927040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT).
    Aksu B; De Beer T; Folestad S; Ketolainen J; Lindén H; Lopes JA; de Matas M; Oostra W; Rantanen J; Weimer M
    Eur J Pharm Sci; 2012 Sep; 47(2):402-5. PubMed ID: 22749874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and establishment of specifications for biopharmaceuticals.
    Davis GC; Riggin RM
    Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality control and analytical techniques for biopharmaceuticals.
    Robinson CJ; Jones C
    Bioanalysis; 2011 Jan; 3(1):81-95. PubMed ID: 21175369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of bioassays for the characterisation and control of biological therapeutic products produced by biotechnology.
    Thorpe R; Wadhwa M; Mire-Sluis A
    Dev Biol Stand; 1997; 91():79-88. PubMed ID: 9413686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid modeling for quality by design and PAT-benefits and challenges of applications in biopharmaceutical industry.
    von Stosch M; Davy S; Francois K; Galvanauskas V; Hamelink JM; Luebbert A; Mayer M; Oliveira R; O'Kennedy R; Rice P; Glassey J
    Biotechnol J; 2014 Jun; 9(6):719-26. PubMed ID: 24806479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA perspective on specifications for biotechnology products--from IND to PLA.
    Murano G
    Dev Biol Stand; 1997; 91():3-13. PubMed ID: 9413677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.
    Jiang M; Severson KA; Love JC; Madden H; Swann P; Zang L; Braatz RD
    Biotechnol Bioeng; 2017 Nov; 114(11):2445-2456. PubMed ID: 28710854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of specifications for biotechnology products--perspective from Europe.
    Trouvin JH
    Dev Biol Stand; 1997; 91():25-30. PubMed ID: 9413679
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality-by-design for biotechnology-related pharmaceuticals.
    Mandenius CF; Graumann K; Schultz TW; Premstaller A; Olsson IM; Petiot E; Clemens C; Welin M
    Biotechnol J; 2009 May; 4(5):600-9. PubMed ID: 19418475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Top ten hot topics in parenteral science and technology.
    Akers MJ; Nail SL; Saffell-Clemmer W
    PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance and quality control for biopharmaceutical products.
    Geigert J
    Pharm Biotechnol; 2002; 14():361-404. PubMed ID: 12189728
    [No Abstract]   [Full Text] [Related]  

  • 18. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Process validation for manufacturing of biologics and biotechnology products. Proceedings of a meeting. September 6-7, 2001. Berlin, Germany.
    Dev Biol (Basel); 2003; 113():3-120. PubMed ID: 15116735
    [No Abstract]   [Full Text] [Related]  

  • 20. A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design.
    Martin-Moe S; Lim FJ; Wong RL; Sreedhara A; Sundaram J; Sane SU
    J Pharm Sci; 2011 Aug; 100(8):3031-3043. PubMed ID: 21425164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.